Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Erblich

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Review of Hematology|March 16, 2018
Treating relapsed follicular lymphomaThomas Erblich, Silvia Montoto
Case Reports in Hematology|July 17, 2024
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated RiskThomas Erblich, Charlotte Manisty, John Gribben
Blood Advances|December 1, 2023
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AMLCarlos Jimenez-Chillon, Jad Othman, David Taussig, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Review of Hematology|March 16, 2018
Treating relapsed follicular lymphomaThomas Erblich, Silvia Montoto
Case Reports in Hematology|July 17, 2024
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated RiskThomas Erblich, Charlotte Manisty, John Gribben
Blood Advances|December 1, 2023
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AMLCarlos Jimenez-Chillon, Jad Othman, David Taussig, et al.
Pageof 1